Clinical Trial Update: Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating recombinant interleukin-7 in HIV-infected individuals on antiretroviral therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV | Phase 1 | Status: COMPLETED